Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Update

30 Apr 2014 12:00

RNS Number : 9054F
Fitbug Holdings PLC
30 April 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 April 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Agrees extension of all loans to mid 2015 and secures additional £1 million loan on attractive terms

Legal action against Fitbit on course for court decision in 2015.

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans to the Company from NW1 Investments Limited and Kifin Limited, a Kirsh Group subsidiary, be extended to 31 July 2015. Other terms remain unchanged including the interest rate which remains at 5%.

 

The Company is also pleased to announce that it has agreed a further £1 million loan ('the Loan') from NW1 Investments Limited ('Loan Holder'). The Loan is repayable by 31 July 2015 and will accrue interest at 5% per annum, payable on a quarterly basis. NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

The independent directors of the Company, being Fergus Kee, Malcolm Fried, Paul Landau, Ann Jones, Geoffrey Simmonds and Andrew Brummer, consider, having consulted with Cantor Fitzgerald Europe, that the terms of the Loan are fair and reasonable in so far as shareholders are concerned.

 

The Company's legal action against Fitbit alleging trademark infringement, as well as unfair competition and unfair business practices, continues to progress and is scheduled to go to trial in the U.S. District Court for the Northern California in early 2015.

 

Fergus Kee, Chairman of Fitbug said, "This term extension on existing loans and the additional loan capital, both on attractive terms, significantly strengthens the Company's financial position at a time of strongly growing demand for wearable technology. We have an exciting pipeline of business ahead and we look forward to developing this and continuing our investment into both our sales strategy and product."

 

**ENDS**

 

For further information contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne

Hybridan LLP

020 7947 4350 / 020 7947 4361

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

Notes

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology providing users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. The Company's main focus is now on building strategic partnerships with organisations that can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

The Fitbug business was founded by Paul Landau, CEO of Fitbug Limited. Fergus Kee, Chairman of the Company is the former Managing Director of Bupa's £2.1 billion turnover UK and North American Division.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIMMMTMBMJBFI
Date   Source Headline
17th Dec 20219:06 amRNSSecond Price Monitoring Extn
17th Dec 20219:00 amRNSPrice Monitoring Extension
17th Dec 20217:01 amRNSTrading Update
17th Dec 20217:00 amRNSTwo-year commercial deal with Azerion
14th Dec 202111:06 amRNSSecond Price Monitoring Extn
14th Dec 202111:00 amRNSPrice Monitoring Extension
13th Dec 202112:05 pmRNSBidstack adds three new titles to its portfolio
13th Dec 202111:06 amRNSSecond Price Monitoring Extn
13th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20212:00 pmRNSBidstack Secures Deal with AAA Game Publisher
9th Dec 20213:22 pmRNSChange of Company Secretary
17th Nov 20217:00 amRNSBidstack expands its portfolio with Dovetail Games
11th Nov 20217:00 amRNSBidstack Serves an Ace with Tennis Clash
8th Nov 20214:35 pmRNSPrice Monitoring Extension
1st Nov 202111:05 amRNSSecond Price Monitoring Extn
1st Nov 202111:00 amRNSPrice Monitoring Extension
25th Oct 20217:00 amRNSBidstack Launches New In-Menu Ad Format
11th Oct 20217:00 amRNSBidstack lands two new titles with Illusion Labs
7th Oct 20212:00 pmRNSBidstack Adds First Interactive Story Game
30th Sep 20217:00 amRNSDirectorate Change
14th Sep 20217:00 amRNSBidstack Scores Third Title From Inlogic
2nd Sep 20217:00 amRNSInterim Results - six months ended 30 June 2021
27th Aug 20218:37 amRNSBidstack land new partnership with Suji Games
26th Aug 20217:00 amRNSMotionlab Interactive partnership
28th Jul 20217:00 amRNSBidstack races ahead with new T-Bull partnership
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:27 pmRNSGrant of Share Options, PDMR Dealing
27th Jul 20212:09 pmRNSTR-1: Notification of major holdings
27th Jul 20217:00 amRNSTR-1: Notification of major holdings
23rd Jul 20211:10 pmRNSReplacement: Admission of Ordinary Shares & TVR
23rd Jul 20218:23 amRNSDirector/PDMR Shareholdings
23rd Jul 20218:13 amRNSNew Director
23rd Jul 20218:05 amRNSAdmission of New Ordinary Shares and TVR
19th Jul 202112:07 pmRNSResults of General Meeting
14th Jul 20217:00 amRNSUpdate on General Meeting and Admission Date
9th Jul 202110:00 amRNSExclusive Partnership with Rebound Capital Games
9th Jul 20217:00 amRNSExclusive Partnership with Nordeus
2nd Jul 20215:54 pmRNSPosting of Circular and Notice of General Meeting
2nd Jul 20211:57 pmRNSInitiation of research coverage
2nd Jul 20219:38 amRNSResults of Fundraise
1st Jul 20215:30 pmRNSProposed New Director
1st Jul 20215:15 pmRNS£10m Fundraise by way of an Accelerated Bookbuild
23rd Jun 20217:00 amRNSExpiry of Block Listing and Total Voting Rights
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:36 pmRNSPrice Monitoring Extension
29th Apr 20216:12 pmRNSReplacement: Board Changes
29th Apr 20217:00 amRNSKatherine Hays joins as Strategic Adviser
22nd Apr 202112:50 pmRNS2021 AGM Results
22nd Apr 20217:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.